Recurrence risk evaluation in stage IB gastric cancer with TP53 codon 72 polymorphism.

Satoshi Nishizuka,Yukimi Ohmori,Takeshi Iwaya,Keisuke Koeda

Recurrence risk evaluation in stage IB gastric cancer with TP53 codon 72 polymorphism.

2019

Satoshi Nishizuka
Yukimi Ohmori
Takeshi Iwaya
Keisuke Koeda

4044Background: Post-operative adjuvant chemotherapy is not currently indicated for Stage IB gastric cancer. However, about 10% of these patients experience recurrence and metastasis. Our previous ...

Keywords:

TP53 Codon 72 Polymorphism
Oncology
Pathology
Stage IB Gastric Cancer
Medicine
Internal medicine
recurrence risk
Metastasis
adjuvant chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations